Biogen Inc. (NASDAQ: BIIB) is a large market cap stock with a market cap of 72327.1. It is in the Biotechnology industry and sector Healthcare, with a current P/E of 19.27, a forward P/E of 15.87 and EPS of 17.13. At a stock price of 316.82 (-4.03%) it has a dividend yield of *TBA.
EPS growth for the last five years have been 31.30%, more recently this last year it has grown by 24.00%. The next year growth is going to be about 3.32% and more long-term 9.01% after five years. EPS growth quarter over quarter is 21.60%. Sales growth for the past five years have been 17.90% and sales growth quarter over quarter is 11.70%.
For performance, Biogen Inc. the past week has seen a gain of 15.00%. For the last month performance for Biogen Inc. is 34.71%. While the last quarter is 20.61% and half year, 24.07%. Finally for the year, performance is 1.77%.
The 52-week high for Biogen Inc., is at -6.41%, and for the 52-week low it comes to a value of 42.06%. The 20-day simple moving average is 21.15% and 16.72% for the 200-day simple moving average.
Volatility for the week is at 3.77%, and for the month it is 2.49%. Biogen Inc., has a target price of 332.5.
In terms of debt, long term debt/equity is 0.57, and for total debt/equity Biogen Inc. has 0.57. The gross margin is 88.20%, while operating margin is 47.90%, the profit margin is 34.00%. The current ratio is 3 and the quick ratio is 2.6.
Insider ownership is at 0.10%, with instituitional ownership at 88.60%. Biogen Inc. has a payout ratio of 0.00%. With the total shares outstanding coming to 219.1. The shares float is 218.5, with the float short at 1.18%, with short ratio coming to 1.29.
In terms of returns, the return on assets see Biogen Inc., get 18.50%, with its returns on investment at 23.50%. Return on equity is 36.60%. So will the investors see the target price of 332.5, reached soon?
Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.